Recent Quotes (30 days)

You have no recent quotes
chg | %

Kedem Pharmaceuticals Inc  

(Public, OTCMKTS:KDMP)   Watch this stock  
Find more results for OTC:GHLV
0.0002
0.0000 (0.00%)
Delayed:   2:41PM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol / Avg. 0.00/736.00
Mkt cap 5,080.00
P/E     -
Div/yield     -
EPS -0.24
Shares 25.39M
Beta 2.19
Inst. own 0%

Key stats and ratios

Q4 (Nov '12) 2012
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -471.46% -308.49%
Return on average equity - -
Employees 3 -
CDP Score - -

Address

Suite 1023, 409 Granville Street
VANCOUVER, BC V6C 1T2
Canada
+1-604-3244844 (Phone)

Website links

Description

Kedem Pharmaceuticals Inc., formerly Global Health Ventures Inc., is a development stage specialty pharmaceutical company engaged in developing platform technology that delivers drugs via the sublingual (under the tongue) route. The Company is also developing oral formulations of drugs, which are focused to cause fewer stomach side effects than formulations of such drugs. Its lifestyle products are related to male sexual enhancement, anti-addiction and energy boosters. The Company's therapeutic products are related to weight loss and pulmonary disease management. The Company's portfolio of products includes X-Excite (male sexual enhancement drug); Relax-B (anti-stress drug); Nico-Z (nicotine replacement product); V-Energy (energy booster product), and T-Slim (appetite suppressor drug).

Officers and directors

Christian Bezy President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
Age: 57